MetaADEDB 2.0 @ LMMD
Lisdexamfetamine Dimesylate
(CETWSOHVEGTIBR-FORAGAHYSA-N)
Structure
SMILES
CS(=O)(=O)O.CS(=O)(=O)O.NCCCC[C@@H](C(=O)N[C@H](Cc1ccccc1)C)N
Molecular Formula:
C17H33N3O7S2
Molecular Weight:
455.590
Log P:
4.1512
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
5
TPSA:
206.64
CAS Number(s):
608137-33-3
Synonym(s)
1.
Lisdexamfetamine Dimesylate
2.
Elvanse
3.
Lis-dexamfetamine Dimesylate
4.
Lisdexamfetamine
5.
NRP-104
6.
NRP104
7.
Vyvanse
8.
Dimesylate, Lis-dexamfetamine
9.
Dimesylate, Lisdexamfetamine
10.
Lis dexamfetamine Dimesylate
11.
NRP 104
External Link(s)
MeSHD000069478
PubChem Compound11597697
CHEMBLCHEMBL1201178
KEGGdr:D04747
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 995
Canada Vigilance: 146
Canada Vigilance
US FAERS
2Product quality issueFAERS: 642
Canada Vigilance: 36
Canada Vigilance
US FAERS
3No adverse eventFAERS: 357US FAERS
4Inappropriate schedule of drug administrationFAERS: 331US FAERS
5HeadacheFAERS: 277
Canada Vigilance: 11

View details

CTD
Canada Vigilance
US FAERS
6AnxietyFAERS: 257
Canada Vigilance: 20
Canada Vigilance
US FAERS
7Feeling abnormalFAERS: 231
Canada Vigilance: 7
Canada Vigilance
US FAERS
8FatigueFAERS: 225
Canada Vigilance: 5
Canada Vigilance
US FAERS
9Weight decreasedFAERS: 215
Canada Vigilance: 8
Canada Vigilance
US FAERS
10Prescribed overdoseFAERS: 188
Canada Vigilance: 11
Canada Vigilance
US FAERS
11Drug dose omissionFAERS: 181US FAERS
12Incorrect dose administeredFAERS: 165
Canada Vigilance: 5
Canada Vigilance
US FAERS
13Wrong technique in product usage processFAERS: 163
Canada Vigilance: 6
Canada Vigilance
US FAERS
14AgitationFAERS: 161
Canada Vigilance: 14
Canada Vigilance
US FAERS
15AngerFAERS: 150
Canada Vigilance: 10
Canada Vigilance
US FAERS
16DizzinessFAERS: 150
Canada Vigilance: 9
20173084CTD
Canada Vigilance
US FAERS
17NauseaFAERS: 150
Canada Vigilance: 9
20173084CTD
Canada Vigilance
US FAERS
18OverdoseFAERS: 136
Canada Vigilance: 12
Canada Vigilance
US FAERS
19SomnolenceFAERS: 135
Canada Vigilance: 5
Canada Vigilance
US FAERS
20CryingFAERS: 127
Canada Vigilance: 4
Canada Vigilance
US FAERS
21VomitingFAERS: 125
Canada Vigilance: 7
18622366CTD
Canada Vigilance
US FAERS
22Product physical issueFAERS: 120
Canada Vigilance: 7
Canada Vigilance
US FAERS
23MalaiseFAERS: 114
Canada Vigilance: 8
Canada Vigilance
US FAERS
24PalpitationsFAERS: 105
Canada Vigilance: 9
Canada Vigilance
US FAERS
25Chest PainFAERS: 101
Canada Vigilance: 3
Canada Vigilance
US FAERS
26Depressed moodFAERS: 101
Canada Vigilance: 6
Canada Vigilance
US FAERS
27Adverse eventFAERS: 97
Canada Vigilance: 1
Canada Vigilance
US FAERS
28TremorFAERS: 81
Canada Vigilance: 2
Canada Vigilance
US FAERS
29Unevaluable eventFAERS: 80
Canada Vigilance: 2
Canada Vigilance
US FAERS
30AlopeciaFAERS: 79US FAERS
31Product use issueFAERS: 79
Canada Vigilance: 8
Canada Vigilance
US FAERS
32TachycardiaFAERS: 74
Canada Vigilance: 6
19785973CTD
Canada Vigilance
US FAERS
33Therapeutic response unexpectedFAERS: 71
Canada Vigilance: 7
Canada Vigilance
US FAERS
34AnorexiaFAERS: 70US FAERS
35AstheniaFAERS: 69
Canada Vigilance: 4
Canada Vigilance
US FAERS
36Drug diversionFAERS: 69US FAERS
37NervousnessFAERS: 69
Canada Vigilance: 3
Canada Vigilance
US FAERS
38Drug prescribing errorFAERS: 68US FAERS
39Feeling jitteryFAERS: 68US FAERS
40Mood swingsFAERS: 64
Canada Vigilance: 5
Canada Vigilance
US FAERS
41ParanoiaFAERS: 64
Canada Vigilance: 5
Canada Vigilance
US FAERS
42Educational problemFAERS: 58US FAERS
43SyncopeFAERS: 56
Canada Vigilance: 4
Canada Vigilance
US FAERS
44Emotional disorderFAERS: 50
Canada Vigilance: 3
Canada Vigilance
US FAERS
45LethargyFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
46NegativismFAERS: 50US FAERS
47PainFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Personality ChangeFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
49Drug effect variableFAERS: 46US FAERS
50Memory impairmentFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
51Wrong technique in drug usage processFAERS: 44US FAERS
52Erectile dysfunctionFAERS: 40US FAERS
53Accidental overdoseFAERS: 39US FAERS
54Emotional distressFAERS: 39US FAERS
55StressFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Visual ImpairmentFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
57BruxismFAERS: 37US FAERS
58Drug abuseFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Flat affectFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
60HypersensitivityFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
61Performance status decreasedFAERS: 37US FAERS
62Abdominal PainFAERS: 36
Canada Vigilance: 2
18622366
20035583
CTD
Canada Vigilance
US FAERS
63Abdominal discomfortFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Initial insomniaFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Drug administered to patient of inappropriate ageFAERS: 35US FAERS
66Drug withdrawal syndromeFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
67DysgeusiaFAERS: 35US FAERS
68RestlessnessFAERS: 34US FAERS
69MydriasisFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Inappropriate schedule of product administrationFAERS: 30
Canada Vigilance: 14
Canada Vigilance
US FAERS
71PruritusFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Intentional product misuseFAERS: 29US FAERS
73Chest discomfortFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
74UrticariaFAERS: 27US FAERS
75Suicide attemptFAERS: 26
Canada Vigilance: 4
Canada Vigilance
US FAERS
76HypophagiaFAERS: 25US FAERS
77Obsessive-Compulsive DisorderFAERS: 25
Canada Vigilance: 2
26621156CTD
Canada Vigilance
US FAERS
78Product tamperingFAERS: 25US FAERS
79Drug effect incompleteFAERS: 24US FAERS
80Drug screen positiveFAERS: 23US FAERS
81EpistaxisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
82ErythemaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Inability to afford medicationFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Drug effect delayedFAERS: 22US FAERS
85ScreamingFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
86ApathyFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
87Bipolar DisorderFAERS: 21
Canada Vigilance: 2
24014142CTD
Canada Vigilance
US FAERS
88AmnesiaFAERS: 20US FAERS
89HostilityFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
90MyalgiaFAERS: 20US FAERS
91TrichotillomaniaFAERS: 20US FAERS
92AcneFAERS: 19US FAERS
93Completed SuicideFAERS: 19US FAERS
94Drug ToleranceFAERS: 19US FAERS
95Euphoric moodFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
96Tardive DyskinesiaFAERS: 19US FAERS
97DehydrationFAERS: 18US FAERS
98Drug DependenceFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
99DystoniaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Intentional drug misuseFAERS: 18US FAERS
101Musculoskeletal stiffnessFAERS: 18US FAERS
102NasopharyngitisFAERS: 1818622366CTD
US FAERS
103Cerebrovascular accidentFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
104ConstipationFAERS: 17US FAERS
105Back PainFAERS: 16US FAERS
106DysarthriaFAERS: 16US FAERS
107DysphemiaFAERS: 16US FAERS
108Growth retardationFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
109Intentional self-injuryFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
110Product storage errorFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
111TinnitusFAERS: 16US FAERS
112Accidental exposure to product by childFAERS: 15US FAERS
113Activities of daily living impairedFAERS: 15US FAERS
114Amphetamines positiveFAERS: 15US FAERS
115HypersomniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Oropharyngeal painFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
117PresyncopeFAERS: 15US FAERS
118Therapy cessationFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
119ArthralgiaFAERS: 14US FAERS
120Cardiac ArrestFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
121FrustrationFAERS: 14US FAERS
122Hallucinations, mixedFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
123PallorFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
124Product taste abnormalFAERS: 14US FAERS
125TachyphreniaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
126Drug dispensing errorFAERS: 13US FAERS
127FlushingFAERS: 13US FAERS
128HungerFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
129Maternal exposure during pregnancyFAERS: 13US FAERS
130Mental impairmentFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
131Neck PainFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Obsessive thoughtsFAERS: 13US FAERS
133RetchingFAERS: 13US FAERS
134ChillsFAERS: 12US FAERS
135Conduct DisorderFAERS: 12US FAERS
136FormicationFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
137HypotensionFAERS: 12US FAERS
138Insurance issueFAERS: 12US FAERS
139Muscle tightnessFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
140Drug screen negativeFAERS: 11US FAERS
141DysphoniaFAERS: 11US FAERS
142HyperacusisFAERS: 11US FAERS
143Middle insomniaFAERS: 11US FAERS
144Oral administration complicationFAERS: 11US FAERS
145SinusitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
146SluggishnessFAERS: 11US FAERS
147AphasiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
148Inappropriate affectFAERS: 10US FAERS
149NephrolithiasisFAERS: 10US FAERS
150Peripheral swellingFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
151RhabdomyolysisFAERS: 10US FAERS
152ThirstFAERS: 10US FAERS
153Toxicity to various agentsFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
154TrismusFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
155AbasiaFAERS: 9US FAERS
156DisorientationFAERS: 9US FAERS
157DyspepsiaFAERS: 9US FAERS
158DysuriaFAERS: 9
Canada Vigilance: 3
20173084CTD
Canada Vigilance
US FAERS
159Electrocardiogram abnormalFAERS: 9US FAERS
160HypermetabolismFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
161Impaired work abilityFAERS: 9US FAERS
162Mental status changesFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
163Psychiatric symptomFAERS: 9US FAERS
164Sexual DysfunctionFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
165TheftFAERS: 9US FAERS
166Urinary IncontinenceFAERS: 9US FAERS
167Urinary tract infectionFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
168Amphetamines negativeFAERS: 8US FAERS
169Change in sustained attentionFAERS: 8US FAERS
170EnuresisFAERS: 8US FAERS
171IncoherentFAERS: 8US FAERS
172Lip swellingFAERS: 8US FAERS
173Myocardial InfarctionFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Physical assaultFAERS: 8US FAERS
175Poor peripheral circulationFAERS: 8US FAERS
176Product packaging quantity issueFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
177SomnambulismFAERS: 8US FAERS
178StaringFAERS: 8US FAERS
179Therapeutic response changedFAERS: 8US FAERS
180Unresponsive to stimuliFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
181Urinary RetentionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
182Accidental exposureFAERS: 7US FAERS
183Atrial FibrillationFAERS: 7US FAERS
184Blood creatine phosphokinase increasedFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
185Blood glucose decreasedFAERS: 7US FAERS
186Burning sensationFAERS: 7US FAERS
187DisabilityFAERS: 7US FAERS
188Drug administration errorFAERS: 7US FAERS
189Ear discomfortFAERS: 7US FAERS
190Excessive eye blinkingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Eye painFAERS: 7US FAERS
192Feeling ColdFAERS: 7US FAERS
193Food cravingFAERS: 7US FAERS
194Frustration tolerance decreasedFAERS: 7US FAERS
195Incorrect product storageFAERS: 7US FAERS
196Joint swellingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
197Nicotine DependenceFAERS: 7US FAERS
198Skin reactionFAERS: 7US FAERS
199UnderweightFAERS: 7US FAERS
200Violence-related symptomFAERS: 7US FAERS
201Accidental exposure to productFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
202CyanosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
203DependenceFAERS: 6US FAERS
204Depressed Level of ConsciousnessFAERS: 6US FAERS
205DiplopiaFAERS: 6US FAERS
206EructationFAERS: 6US FAERS
207Eye irritationFAERS: 6US FAERS
208HyperventilationFAERS: 6US FAERS
209HypomaniaFAERS: 6US FAERS
210InfluenzaFAERS: 6US FAERS
211Loss of personal independence in daily activitiesFAERS: 6US FAERS
212Nonspecific reactionFAERS: 6US FAERS
213PancreatitisFAERS: 6US FAERS
214PhotophobiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
215Rebound effectFAERS: 6US FAERS
216Restless Legs SyndromeFAERS: 6US FAERS
217StomatitisFAERS: 6US FAERS
218Urine amphetamine positiveFAERS: 6US FAERS
219YawningFAERS: 6US FAERS
220Angina PectorisFAERS: 5US FAERS
221Dental cariesFAERS: 5US FAERS
222Diabetes MellitusFAERS: 5US FAERS
223Drug exposure during pregnancyFAERS: 5US FAERS
224Drug ineffective for unapproved indicationFAERS: 5US FAERS
225FlatulenceFAERS: 5US FAERS
226GlaucomaFAERS: 5US FAERS
227Intentional product use issueFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
228Limb discomfortFAERS: 5US FAERS
229MalabsorptionFAERS: 5US FAERS
230Musculoskeletal PainFAERS: 5US FAERS
231Oral painFAERS: 5US FAERS
232Pharmaceutical product complaintFAERS: 5US FAERS
233PolydipsiaFAERS: 5US FAERS
234Poor quality sleepFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Pressure of speechFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Product label issueFAERS: 5US FAERS
237Product substitution issueFAERS: 5US FAERS
238Respiratory arrestFAERS: 5US FAERS
239SwellingFAERS: 5US FAERS
240ThrombosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
241nervous system disorderFAERS: 5US FAERS
242treatment failureFAERS: 5US FAERS
243Abnormal weight gainFAERS: 4US FAERS
244Accidental drug intake by childFAERS: 4US FAERS
245Alanine Aminotransferase IncreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
246AsthmaFAERS: 4US FAERS
247BlepharospasmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
248BlindnessFAERS: 4US FAERS
249Blood glucose increasedFAERS: 4US FAERS
250Blood prolactin increasedFAERS: 4US FAERS
251Capsule physical issueFAERS: 4US FAERS
252CardiomegalyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
253ChromatopsiaFAERS: 4US FAERS
254Cold sweatFAERS: 4US FAERS
255Conversion disorderFAERS: 4US FAERS
256DeafnessFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
257DroolingFAERS: 4US FAERS
258Excessive masturbationFAERS: 4US FAERS
259Flight of ideasFAERS: 4US FAERS
260Foaming at mouthFAERS: 4US FAERS
261Head discomfortFAERS: 4US FAERS
262HyperthyroidismFAERS: 4US FAERS
263HypothyroidismFAERS: 4US FAERS
264ImpatienceFAERS: 4US FAERS
265Incorrect route of drug administrationFAERS: 4US FAERS
266LacerationFAERS: 4US FAERS
267MalnutritionFAERS: 4US FAERS
268Morbid thoughtsFAERS: 4US FAERS
269Multiple SclerosisFAERS: 4US FAERS
270Negative thoughtsFAERS: 4US FAERS
271Oppositional Defiant DisorderFAERS: 4US FAERS
272Post-Traumatic Stress DisorderFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Product physical consistency issueFAERS: 4US FAERS
274Pulmonary EmbolismFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
275Retinal DetachmentFAERS: 4US FAERS
276SchizophreniaFAERS: 423756608CTD
US FAERS
277Skin lesionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
278Supraventricular tachycardiaFAERS: 4US FAERS
279Throat irritationFAERS: 4US FAERS
280Tobacco userFAERS: 4US FAERS
281Tongue bitingFAERS: 4US FAERS
282Urine amphetamine negativeFAERS: 4US FAERS
283jaundiceFAERS: 4US FAERS
284Acute myocardial infarctionFAERS: 3US FAERS
285Alcohol abuseFAERS: 3US FAERS
286Anaphylactic shockFAERS: 3US FAERS
287AnorgasmiaFAERS: 3US FAERS
288AnuriaFAERS: 3US FAERS
289Aspartate Aminotransferase IncreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
290AsphyxiaFAERS: 3US FAERS
291Bipolar I disorderFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Blood cholesterol increasedFAERS: 3US FAERS
293Blood potassium decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
294CatatoniaFAERS: 3US FAERS
295CholelithiasisFAERS: 3US FAERS
296Compulsive lip bitingFAERS: 3US FAERS
297Dark circles under eyesFAERS: 3US FAERS
298Decreased eye contactFAERS: 3US FAERS
299DeliriumFAERS: 3US FAERS
300Delusional perceptionFAERS: 3US FAERS
301DiscomfortFAERS: 3US FAERS
302Dissociative disorderFAERS: 3US FAERS
303Emotional povertyFAERS: 3US FAERS
304Failure to ThriveFAERS: 3US FAERS
305Feelings of worthlessnessFAERS: 3US FAERS
306Food AllergyFAERS: 3US FAERS
307HemiparesisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
308HepatitisFAERS: 3US FAERS
309HyperphagiaFAERS: 3US FAERS
310HypervigilanceFAERS: 3US FAERS
311Hypoaesthesia facialFAERS: 3US FAERS
312Impaired driving abilityFAERS: 3US FAERS
313InfectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
314Infectious MononucleosisFAERS: 3US FAERS
315Lack of spontaneous speechFAERS: 3US FAERS
316Livedo ReticularisFAERS: 3US FAERS
317Migraine with AuraFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
318MoaningFAERS: 3US FAERS
319MonoplegiaFAERS: 3US FAERS
320MoroseFAERS: 3US FAERS
321Muscle RigidityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
322MyopiaFAERS: 3US FAERS
323Penile size reducedFAERS: 3US FAERS
324PhlebitisFAERS: 3US FAERS
325Poor quality product administeredFAERS: 3US FAERS
326Product dose omissionFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
327Product solubility abnormalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Rash erythematousFAERS: 3US FAERS
329Respiratory distressFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
330ScotomaFAERS: 3US FAERS
331Sexual abuseFAERS: 3US FAERS
332Skin UlcerFAERS: 3US FAERS
333SoliloquyFAERS: 3US FAERS
334Spontaneous penile erectionFAERS: 3US FAERS
335Stevens-Johnson SyndromeFAERS: 325811541CTD
US FAERS
336StrabismusFAERS: 3US FAERS
337StubbornnessFAERS: 3US FAERS
338Suspected product tamperingFAERS: 3US FAERS
339TensionFAERS: 3US FAERS
340Therapeutic product effect decreasedFAERS: 3
Canada Vigilance: 43
Canada Vigilance
US FAERS
341Therapeutic response delayedFAERS: 3US FAERS
342Therapy changeFAERS: 3US FAERS
343Thirst decreasedFAERS: 3US FAERS
344ThrombocytopeniaFAERS: 3US FAERS
345Tongue movement disturbanceFAERS: 3US FAERS
346VertigoFAERS: 3US FAERS
347White blood cell count decreasedFAERS: 3US FAERS
348skin abrasionFAERS: 3US FAERS
349Acute psychosisFAERS: 2US FAERS
350Alcohol interactionFAERS: 2US FAERS
351Alcohol poisoningFAERS: 2US FAERS
352Altered state of consciousnessFAERS: 2US FAERS
353Altered visual depth perceptionFAERS: 2US FAERS
354Amaurosis FugaxFAERS: 2US FAERS
355AngioedemaFAERS: 2US FAERS
356AnhedoniaFAERS: 2US FAERS
357Antibody test positiveFAERS: 2US FAERS
358AphoniaFAERS: 2US FAERS
359ArthropathyFAERS: 2US FAERS
360AsthenopiaFAERS: 2US FAERS
361Blood pressure fluctuationFAERS: 2US FAERS
362Blood testosterone decreasedFAERS: 2US FAERS
363Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
364Blood urine presentFAERS: 2US FAERS
365Blue Toe SyndromeFAERS: 2US FAERS
366Body height below normalFAERS: 2US FAERS
367Bone painFAERS: 2US FAERS
368BradyphreniaFAERS: 2US FAERS
369Cardiac discomfortFAERS: 2US FAERS
370CheilitisFAERS: 2US FAERS
371ChromaturiaFAERS: 2US FAERS
372Chronic Fatigue SyndromeFAERS: 2US FAERS
373Coronary Artery DiseaseFAERS: 2US FAERS
374Discontinued product administeredFAERS: 2US FAERS
375DissociationFAERS: 2US FAERS
376Drug effective for unapproved indicationFAERS: 2US FAERS
377Dry skinFAERS: 2US FAERS
378DysgraphiaFAERS: 2US FAERS
379DyslexiaFAERS: 2US FAERS
380Ear congestionFAERS: 2US FAERS
381EpilepsyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
382ExophthalmosFAERS: 2US FAERS
383Expired product administeredFAERS: 2US FAERS
384Exposure during breast feedingFAERS: 2US FAERS
385Extra dose administeredFAERS: 2US FAERS
386Fear-related avoidance of activitiesFAERS: 2US FAERS
387Feeling of body temperature changeFAERS: 2US FAERS
388FibromyalgiaFAERS: 2US FAERS
389Fight in schoolFAERS: 2US FAERS
390GastritisFAERS: 2US FAERS
391GastroenteritisFAERS: 2US FAERS
392Gastrointestinal PainFAERS: 2US FAERS
393GlossitisFAERS: 2US FAERS
394Heat StrokeFAERS: 2US FAERS
395HomicideFAERS: 2US FAERS
396Hypertensive crisisFAERS: 2US FAERS
397Incorrect drug administration durationFAERS: 2US FAERS
398Joint injuryFAERS: 2US FAERS
399Laboratory test interferenceFAERS: 2US FAERS
400LeukocytosisFAERS: 2US FAERS
401LeukopeniaFAERS: 2US FAERS
402Libido disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
403Limb injuryFAERS: 2US FAERS
404Medication residue presentFAERS: 2US FAERS
405MenopauseFAERS: 2US FAERS
406Mouth swellingFAERS: 2US FAERS
407Muscle FatigueFAERS: 2US FAERS
408Musculoskeletal chest painFAERS: 2US FAERS
409Musculoskeletal discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
410Myasthenia GravisFAERS: 2US FAERS
411MyocarditisFAERS: 2US FAERS
412Nail pickingFAERS: 2US FAERS
413NeuralgiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
414NeurodermatitisFAERS: 2US FAERS
415Night sweatsFAERS: 2US FAERS
416Obsessive-compulsive symptomFAERS: 2US FAERS
417Oculogyric crisisFAERS: 2US FAERS
418Optic NeuropathyFAERS: 2US FAERS
419OverweightFAERS: 2US FAERS
420Personal relationship issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
421PolyuriaFAERS: 2US FAERS
422PregnancyFAERS: 2US FAERS
423Product administration errorFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
424Product dosage form issueFAERS: 2US FAERS
425Product formulation issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
426Product use complaintFAERS: 2US FAERS
427ProteinuriaFAERS: 2US FAERS
428Pulmonary HypertensionFAERS: 2US FAERS
429Retinal Vein OcclusionFAERS: 2US FAERS
430Retrograde ejaculationFAERS: 2US FAERS
431SclerodermaFAERS: 2US FAERS
432Seizure like phenomenaFAERS: 2US FAERS
433SemenuriaFAERS: 2US FAERS
434Serotonin SyndromeFAERS: 2US FAERS
435Sinus headacheFAERS: 2US FAERS
436Skin WrinklingFAERS: 2US FAERS
437Skin lacerationFAERS: 2US FAERS
438Sleep ParalysisFAERS: 2US FAERS
439Subcutaneous EmphysemaFAERS: 2US FAERS
440Sudden deathFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
441Temperature intoleranceFAERS: 2US FAERS
442Tongue blisteringFAERS: 2US FAERS
443Transcription medication errorFAERS: 2US FAERS
444Urine flow decreasedFAERS: 2US FAERS
445VasospasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
446Ventricular FibrillationFAERS: 2US FAERS
447Abdominal symptomFAERS: 1US FAERS
448Abnormal sleep-related eventFAERS: 1US FAERS
449AbuliaFAERS: 1US FAERS
450Accidental deathFAERS: 1US FAERS
451AcidosisFAERS: 1US FAERS
452Adenoidal disorderFAERS: 1US FAERS
453Adjustment disorder with mixed anxiety and depressed moodFAERS: 1US FAERS
454AgeusiaFAERS: 1US FAERS
455AgoraphobiaFAERS: 1US FAERS
456Alcohol IntoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
457Allergic reaction to excipientFAERS: 1US FAERS
458Allergic sinusitisFAERS: 1US FAERS
459Ammonia increasedFAERS: 1US FAERS
460Anaphylactoid ReactionFAERS: 1US FAERS
461Anorexia NervosaFAERS: 1US FAERS
462Anorexia and bulimia syndromeFAERS: 1US FAERS
463AnoxiaFAERS: 1US FAERS
464Antisocial Personality DisorderFAERS: 1US FAERS
465Aortic AneurysmFAERS: 1US FAERS
466AphagiaFAERS: 1US FAERS
467Aphthous StomatitisFAERS: 1US FAERS
468Apparent deathFAERS: 1US FAERS
469Apparent life threatening eventFAERS: 1US FAERS
470Arterial InjuryFAERS: 1US FAERS
471ArteriosclerosisFAERS: 1US FAERS
472ArthritisFAERS: 1US FAERS
473Arthropod biteFAERS: 1US FAERS
474AtaxiaFAERS: 1US FAERS
475Atrioventricular BlockFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
476Autoimmune hepatitisFAERS: 1US FAERS
477AutophobiaFAERS: 1US FAERS
478Behavioural and psychiatric symptoms of dementiaFAERS: 1US FAERS
479BelligerenceFAERS: 1US FAERS
480Benign Rolandic EpilepsyFAERS: 1US FAERS
481Bipolar II disorderFAERS: 1US FAERS
482Bladder painFAERS: 1US FAERS
483Blood alkaline phosphatase increasedFAERS: 1US FAERS
484Blood cortisol increasedFAERS: 1US FAERS
485Blood creatine phosphokinase abnormalFAERS: 1US FAERS
486Blood glucose abnormalFAERS: 1US FAERS
487Blood phosphorus decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
488Blood phosphorus increasedFAERS: 1US FAERS
489Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
490Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
491Blood urea increasedFAERS: 1US FAERS
492Blunted affectFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
493Body temperature fluctuationFAERS: 1US FAERS
494Bowel movement irregularityFAERS: 1US FAERS
495BradycardiaFAERS: 1US FAERS
496Brain DeathFAERS: 1US FAERS
497Breast tendernessFAERS: 1US FAERS
498BronchitisFAERS: 1US FAERS
499BronchospasmFAERS: 1US FAERS
500Bulimia NervosaFAERS: 1US FAERS
501CYP2D6 polymorphismFAERS: 1US FAERS
502Capillary nail refill test abnormalFAERS: 1US FAERS
503Capsule issueFAERS: 1US FAERS
504Cardiac FlutterFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Cardiac enzymes increasedFAERS: 1US FAERS
506Cardiac imaging procedure abnormalFAERS: 1US FAERS
507CataractFAERS: 1US FAERS
508CellulitisFAERS: 1US FAERS
509Central nervous system lesionFAERS: 1US FAERS
510Cerebral atrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
511Cerebral cystFAERS: 1US FAERS
512Cervix carcinomaFAERS: 1US FAERS
513Choking sensationFAERS: 1US FAERS
514ClonusFAERS: 1US FAERS
515ClubbingFAERS: 1US FAERS
516Cogwheel RigidityFAERS: 1US FAERS
517Cold exposure injuryFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
518ColitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
519Compulsive hoardingFAERS: 1US FAERS
520Concomitant disease aggravatedFAERS: 1US FAERS
521ConjunctivitisFAERS: 1US FAERS
522Contact lens intoleranceFAERS: 1US FAERS
523Cortisol increasedFAERS: 1US FAERS
524CystitisFAERS: 1US FAERS
525Deep Vein ThrombosisFAERS: 1US FAERS
526Dehydroepiandrosterone increasedFAERS: 1US FAERS
527Delusional disorder, unspecified typeFAERS: 1US FAERS
528Dependent Personality DisorderFAERS: 1US FAERS
529Depression suicidalFAERS: 1US FAERS
530DermatitisFAERS: 1US FAERS
531Diabetic KetoacidosisFAERS: 1US FAERS
532Diffuse alopeciaFAERS: 1US FAERS
533Disseminated Intravascular CoagulationFAERS: 1US FAERS
534Dreamy stateFAERS: 1US FAERS
535Drug abuserFAERS: 1US FAERS
536Drug clearance increasedFAERS: 1US FAERS
537Drug effect faster than expectedFAERS: 1US FAERS
538Drug exposure via breast milkFAERS: 1US FAERS
539Drug level increasedFAERS: 1US FAERS
540Drug resistanceFAERS: 1US FAERS
541Drug screen false positiveFAERS: 1US FAERS
542Drug therapeutic incompatibilityFAERS: 1US FAERS
543Drug titration errorFAERS: 1US FAERS
544Drug toxicityFAERS: 1US FAERS
545Ear abrasionFAERS: 1US FAERS
546Economic problemFAERS: 1US FAERS
547Ectopic PregnancyFAERS: 1US FAERS
548EczemaFAERS: 1US FAERS
549Electrocardiogram changeFAERS: 1US FAERS
550Elevated moodFAERS: 1US FAERS
551EnterobiasisFAERS: 1US FAERS
552Environmental ExposureFAERS: 1US FAERS
553Enzyme InductionFAERS: 1US FAERS
554Enzyme abnormalityFAERS: 1US FAERS
555Erythema MultiformeFAERS: 1US FAERS
556Exposure to unspecified agentFAERS: 1US FAERS
557Exposure via body fluidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
558Extraocular Muscle ParesisFAERS: 1US FAERS
559Eyelid Function DisorderFAERS: 1US FAERS
560Eyelid irritationFAERS: 1US FAERS
561Facial PainFAERS: 1US FAERS
562Facial paralysisFAERS: 1US FAERS
563False positive laboratory resultFAERS: 1US FAERS
564Food PoisoningFAERS: 1US FAERS
565Food hoardingFAERS: 1US FAERS
566Gastric hypermotilityFAERS: 1US FAERS
567Gastric ulcerFAERS: 1US FAERS
568Gastrointestinal motility disorderFAERS: 1US FAERS
569Gastrointestinal procedural complicationFAERS: 1US FAERS
570General physical condition abnormalFAERS: 1US FAERS
571General physical health deteriorationFAERS: 1US FAERS
572General symptomFAERS: 1US FAERS
573Genital painFAERS: 1US FAERS
574Gingival RecessionFAERS: 1US FAERS
575Gingival discomfortFAERS: 1US FAERS
576GingivitisFAERS: 1US FAERS
577Gluten sensitivityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
578GoutFAERS: 1US FAERS
579Growth failureFAERS: 1US FAERS
580Head BangingFAERS: 1US FAERS
581Heat ExhaustionFAERS: 1US FAERS
582Hepatic infiltration eosinophilicFAERS: 1US FAERS
583Hepatitis CFAERS: 1US FAERS
584Hormone level abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
585HyperparathyroidismFAERS: 1US FAERS
586Hypertrophy of tongue papillaeFAERS: 1US FAERS
587HypogeusiaFAERS: 1US FAERS
588HypohidrosisFAERS: 1US FAERS
589HypokinesiaFAERS: 1US FAERS
590HypometabolismFAERS: 1US FAERS
591Hypothalamo-pituitary disorderFAERS: 1US FAERS
592HypoventilationFAERS: 1US FAERS
593HypoxiaFAERS: 1US FAERS
594Illness anxiety disorderFAERS: 1US FAERS
595ImmobileFAERS: 1US FAERS
596Impaired gastric emptyingFAERS: 1US FAERS
597Implantable cardiac monitor insertionFAERS: 1US FAERS
598IncontinenceFAERS: 1US FAERS
599Incorrect product administration durationFAERS: 1US FAERS
600Incorrect route of product administrationFAERS: 1US FAERS
601Incorrect storage of drugFAERS: 1US FAERS
602Increased upper airway secretionFAERS: 1US FAERS
603Intentional dose omissionFAERS: 1US FAERS
604Intercepted drug dispensing errorFAERS: 1US FAERS
605Intracranial AneurysmFAERS: 1US FAERS
606Irregular breathingFAERS: 1US FAERS
607Irritable Bowel SyndromeFAERS: 1US FAERS
608Joint stiffnessFAERS: 1US FAERS
609KetoacidosisFAERS: 1US FAERS
610KoilonychiaFAERS: 1US FAERS
611LaryngospasmFAERS: 1US FAERS
612LazinessFAERS: 1US FAERS
613Lid sulcus deepenedFAERS: 1US FAERS
614Ligament ruptureFAERS: 1US FAERS
615Lip pruritusFAERS: 1US FAERS
616Loose toothFAERS: 1US FAERS
617Low birth weight babyFAERS: 1US FAERS
618Lower respiratory tract congestionFAERS: 1US FAERS
619Lower respiratory tract infectionFAERS: 1US FAERS
620Lyme DiseaseFAERS: 1US FAERS
621LymphadenopathyFAERS: 1US FAERS
622Lymphocyte count decreasedFAERS: 1US FAERS
623LymphocytosisFAERS: 1US FAERS
624MaculeFAERS: 1US FAERS
625Medical dietFAERS: 1US FAERS
626Medication tamperingFAERS: 1US FAERS
627Meniscus injuryFAERS: 1US FAERS
628MenorrhagiaFAERS: 1US FAERS
629Mitral Valve StenosisFAERS: 1US FAERS
630Muscle strainFAERS: 1US FAERS
631MyelitisFAERS: 1US FAERS
632Myocardial necrosis marker increasedFAERS: 1US FAERS
633NarcolepsyFAERS: 1US FAERS
634Nasal FlaringFAERS: 1US FAERS
635Nasal discomfortFAERS: 1US FAERS
636Neuroleptic Malignant SyndromeFAERS: 1US FAERS
637Neurotransmitter level alteredFAERS: 1US FAERS
638NeutropeniaFAERS: 1US FAERS
639Non-cardiac chest painFAERS: 1US FAERS
640Noninfective gingivitisFAERS: 1US FAERS
641Nutritional condition abnormalFAERS: 1US FAERS
642NystagmusFAERS: 1US FAERS
643ObesityFAERS: 1US FAERS
644Ocular HypertensionFAERS: 1US FAERS
645Ocular discomfortFAERS: 1US FAERS
646OnychomycosisFAERS: 1US FAERS
647Opiates positiveFAERS: 1US FAERS
648OpisthotonusFAERS: 1US FAERS
649Oral dischargeFAERS: 1US FAERS
650Oral mucosal eruptionFAERS: 1US FAERS
651Oral pruritusFAERS: 1US FAERS
652Oromandibular dystoniaFAERS: 1US FAERS
653Oropharyngeal discomfortFAERS: 1US FAERS
654Orthostatic hypertensionFAERS: 1US FAERS
655OsteopeniaFAERS: 1US FAERS
656OsteoporosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
657OtotoxicityFAERS: 1US FAERS
658Pain of skinFAERS: 1US FAERS
659Pancreatic Enzymes DecreasedFAERS: 1US FAERS
660Paranasal sinus discomfortFAERS: 1US FAERS
661Partner stressFAERS: 1US FAERS
662Paternal exposure before pregnancyFAERS: 1US FAERS
663Patient dissatisfaction with treatmentFAERS: 1US FAERS
664Pelvic PainFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
665Pelvic fluid collectionFAERS: 1US FAERS
666Peptic UlcerFAERS: 1US FAERS
667Peripheral venous diseaseFAERS: 1US FAERS
668Peritonsillar AbscessFAERS: 1US FAERS
669Physical disabilityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
670PiloerectionFAERS: 1US FAERS
671Pituitary infarctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
672PneumothoraxFAERS: 1US FAERS
673PoisoningFAERS: 1US FAERS
674PolydactylyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675Poor personal hygieneFAERS: 1US FAERS
676Portal Vein ThrombosisFAERS: 1US FAERS
677Postural Orthostatic Tachycardia SyndromeFAERS: 1US FAERS
678Pre-existing condition improvedFAERS: 1US FAERS
679Precocious PubertyFAERS: 1US FAERS
680Premature EjaculationFAERS: 1US FAERS
681Premature baby deathFAERS: 1US FAERS
682Premenstrual syndromeFAERS: 1US FAERS
683Prescribed underdoseFAERS: 1US FAERS
684PriapismFAERS: 1US FAERS
685Product availability issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
686Product comminglingFAERS: 1US FAERS
687Product complaintFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
688Product contamination physicalFAERS: 1US FAERS
689Product label on wrong productFAERS: 1US FAERS
690Product lot number issueFAERS: 1US FAERS
691Product prescribing errorFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
692Product prescribing issueFAERS: 1US FAERS
693Product quality control issueFAERS: 1US FAERS
694Product use in unapproved indicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
695Pulmonary Valve StenosisFAERS: 1US FAERS
696PurgingFAERS: 1US FAERS
697Quality of life decreasedFAERS: 1US FAERS
698Radicular painFAERS: 1US FAERS
699Reaction to excipientFAERS: 1US FAERS
700Rebound psychosisFAERS: 1US FAERS
701Renal painFAERS: 1US FAERS
702Residual urineFAERS: 1US FAERS
703Respiratory FailureFAERS: 1US FAERS
704Retrograde amnesiaFAERS: 1US FAERS
705Rheumatic FeverFAERS: 1US FAERS
706Rheumatoid ArthritisFAERS: 1US FAERS
707Right Ventricular HypertrophyFAERS: 1US FAERS
708Right ventricular failureFAERS: 1US FAERS
709Salt cravingFAERS: 1US FAERS
710ScabFAERS: 1US FAERS
711School refusalFAERS: 1US FAERS
712Sensitive skinFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
713Serum SicknessFAERS: 1US FAERS
714ShockFAERS: 1US FAERS
715Simple Partial SeizuresFAERS: 1US FAERS
716Sinus ArrhythmiaFAERS: 1US FAERS
717Sinus TachycardiaFAERS: 1US FAERS
718Sinus rhythmFAERS: 1US FAERS
719Sjogren's SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
720Skin cosmetic procedureFAERS: 1US FAERS
721Skin noduleFAERS: 1US FAERS
722Skin test positiveFAERS: 1US FAERS
723Sleep TalkingFAERS: 1US FAERS
724Slow speechFAERS: 1US FAERS
725SneezingFAERS: 1US FAERS
726SnoringFAERS: 1US FAERS
727Spinal column stenosisFAERS: 1US FAERS
728Spontaneous ejaculationFAERS: 1US FAERS
729Status EpilepticusFAERS: 1US FAERS
730Stress at workFAERS: 1US FAERS
731StuporFAERS: 1US FAERS
732Sudden onset of sleepFAERS: 1US FAERS
733SunburnFAERS: 1US FAERS
734Sympathomimetic EffectFAERS: 1US FAERS
735Symptom maskedFAERS: 1US FAERS
736Symptom recurrenceFAERS: 1US FAERS
737Synovial CystFAERS: 1US FAERS
738Tablet issueFAERS: 1US FAERS
739TachyphylaxisFAERS: 1US FAERS
740Tension HeadacheFAERS: 1US FAERS
741TetanyFAERS: 1US FAERS
742Therapeutic product effect delayedFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
743Therapeutic product effect variableFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
744Therapy non-responderFAERS: 1US FAERS
745Thermal burnFAERS: 1US FAERS
746Throat clearingFAERS: 1US FAERS
747Tinea crurisFAERS: 1US FAERS
748Tongue discomfortFAERS: 1US FAERS
749Tongue erythemaFAERS: 1US FAERS
750ToothacheFAERS: 1US FAERS
751Toxic Epidermal NecrolysisFAERS: 1US FAERS
752Toxicologic test abnormalFAERS: 1US FAERS
753TrichorrhexisFAERS: 1US FAERS
754Type III immune complex mediated reactionFAERS: 1US FAERS
755Urinary hesitationFAERS: 1US FAERS
756Urine antimony increasedFAERS: 1US FAERS
757Urine output increasedFAERS: 1US FAERS
758Urological examination abnormalFAERS: 1US FAERS
759VIIth nerve paralysisFAERS: 1US FAERS
760Vaginal DischargeFAERS: 1US FAERS
761VasculitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
762Vertebral Artery DissectionFAERS: 1US FAERS
763Viral upper respiratory tract infectionFAERS: 1US FAERS
764Visual disturbanceFAERS: 1US FAERS
765Vitamin D DeficiencyFAERS: 1US FAERS
766Vitreous floatersFAERS: 1US FAERS
767Vulvovaginal drynessFAERS: 1US FAERS
768Vulvovaginal pruritusFAERS: 1US FAERS
769WheezingFAERS: 1US FAERS
770White matter lesionFAERS: 1US FAERS
771Wrong drugFAERS: 1US FAERS
772Wrong drug administeredFAERS: 1US FAERS
773Wrong patient received productFAERS: 1US FAERS
774X-ray abnormalFAERS: 1US FAERS
775heart rateFAERS: 1US FAERS
776pH body fluid abnormalFAERS: 1US FAERS
777Anal spasmCanada Vigilance: 1Canada Vigilance
778Anxiety Disorders19785973CTD
779Benign Prostatic HyperplasiaCanada Vigilance: 1Canada Vigilance
780Disruptive, Impulse Control, and Conduct Disorders26621156CTD
781Disturbance in sexual arousalCanada Vigilance: 1Canada Vigilance
782Dyspnea19785973CTD
783Feeding and Eating Disorders19318601CTD
784Genito-pelvic pain/penetration disorderCanada Vigilance: 1Canada Vigilance
785PharyngitisCanada Vigilance: 1Canada Vigilance
786Product administered to patient of inappropriate ageCanada Vigilance: 1Canada Vigilance
787Psychomotor Agitation20173084CTD
788Respiratory Tract Infections28383364CTD
789Sleep Initiation and Maintenance Disorders

View details

CTD
790Spermatozoa abnormalCanada Vigilance: 1Canada Vigilance
791Suspected suicide attemptCanada Vigilance: 2Canada Vigilance
792Swelling of eyelidCanada Vigilance: 1Canada Vigilance
793Therapeutic product effect incompleteCanada Vigilance: 4Canada Vigilance
794Therapeutic product effect increasedCanada Vigilance: 3Canada Vigilance
795Therapy partial responderCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.